Michael Clayman
Chairman bij Anokion SA
Profiel
Founder of Flexion Therapeutics, Inc., Michael D.
Clayman is a businessperson who has been at the head of 5 different companies and presently occupies the position of Non-Executive Chairman for Anokion SA, Chairman of Ribometrix, Inc. and Chairman at Nido Biosciences, Inc. He is also on the board of Kanyos Bio, Inc. (former Chairman).
In the past Dr. Clayman was General Manager-Chorus at Eli Lilly & Co. and Vice President at Lilly Research Laboratories (a subsidiary of Eli Lilly & Co.), President, Chief Executive Officer & Director at Flexion Therapeutics, Inc., General Manager at Chorus Group Ltd., Head-Global Regulatory Affairs at Abbott Cardiovascular Systems, Inc. and Assistant Professor at Perelman School of Medicine.
He received an undergraduate degree from Yale University and a doctorate from UC San Diego School of Medicine.
Actieve functies van Michael Clayman
Bedrijven | Functie | Begin |
---|---|---|
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Chairman | 14-06-2018 |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Chairman | 27-09-2019 |
Nido Biosciences, Inc.
Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Chairman | 01-08-2022 |
Eerdere bekende functies van Michael Clayman
Bedrijven | Functie | Einde |
---|---|---|
FLEXION THERAPEUTICS, INC. | Chief Executive Officer | 19-11-2021 |
AKEBIA THERAPEUTICS, INC. | Director/Board Member | 12-12-2018 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | 01-01-2007 |
Abbott Cardiovascular Systems, Inc.
Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. | General Counsel | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Opleiding van Michael Clayman
Yale University | Undergraduate Degree |
UC San Diego School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Abbott Cardiovascular Systems, Inc.
Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. | Health Technology |
Chorus Group Ltd.
Chorus Group Ltd. Engineering & ConstructionIndustrial Services Chorus Group Ltd. provides interior design and refurbishment services. It offer services to leisure, retail and public sectors, commercial offices and hotels. The company was founded on February 26, 1996 and is headquartered in Barnet, the United Kingdom. | Industrial Services |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
Nido Biosciences, Inc.
Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |